Future Study With Tolvaptan in Acute Heart Failure

Outcome Study With Tolvaptan) and AQUAMARINE (Answering questions on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure) demonstrated incremental weight loss and improved dyspnea without worsening renal function.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-01, Vol.69 (4), p.467-467
Main Author: Goldsmith, Steven R., MD
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Dyspnea
Heart failure
Internal Medicine
Prescription drugs
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Outcome Study With Tolvaptan) and AQUAMARINE (Answering questions on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure) demonstrated incremental weight loss and improved dyspnea without worsening renal function.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.11.032